Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized

The latest @IBCG_BladderCA consensus in @EUplatinum offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate 🧵1/5

#BladderCancer #AUA25 #OncSurgery #PatientCenteredCare @shilpaonc @achoud72 @FaltasLab @mouwlab @AndreaNecchi @PGrivasMDPhD @UrogerliMD @danielgrass 🏛️ The backbone of bladder preservation is Trimodal Therapy (TMT):
🔹 Maximal TURBT
🔹 Radiation therapy
🔹 Concurrent chemo (cisplatin, 5-FU + MMC, gemcitabine, or carbogen + nicotinamide)
TMT can offer survival outcomes on par with cystectomy for well select patients @AlisonBirtle @Prof_Nick_James @Uromigos @scserendipity1 @DrFelixGuerrero 🧵2/5

Join us at #AUA23 for our
2nd AUA-IBCG #BladderCancer Forum
Sun, April 30th 2 - 5 pm
@UrogerliMD @paolo_gontero @garysteinbergmd @SWilliams_MD @uromc @tbivala1 @spsutkaMD @SimaPorten @bbmdmsk @AStenzl @JoshMeeks @WesKassouf @PGrivasMDPhD @nnavai @MaxKates @shilpaonc @MariaJRibal Let's get some polls going to help our debaters! #AUA23 #AUA2023 @IBCG_BladderCA @AmerUrological @uromc @tbivala1 @joanfundi @siadaneshmand @JimCatto @UrogerliMD @SWilliams_MD @urotoday @BladderCancerUS

Poll #1a Optimal TURBT:
Do Skilled Urologists Really Need PDD for TURBT?

Join us at #EAU23 for our Rapid Fire Debate #BladderCancer Session
Sat, March 11, 3:15 pm

@MarekBabjuk @joanfundi @paolo_gontero @slernerbcmedu1 @UrogerliMD @MRoupret @LAUrology_NL @ParamMariappan @JBjerggaard @JimCatto @amassonlecomte @DrShariat @AndreaNecchi @AStenzl @Uroweb Help our debaters prep with your responses
Poll #1a: Does PDD/NBI etc help alter natural history of NMIBC?

@joanfundi @MarekBabjuk